Disclosing Hypoalbuminemia: A Lupus Protein-Losing Enteropathy (Lupple) Report
DOI:
https://doi.org/10.60591/crspmi.46Keywords:
Hypoalbuminemia, Protein Losing Enteropathy, Systemic Lupus erythematosusAbstract
Protein-losing enteropathy (PLE) is characterized by generalized oedema and severe hypoalbuminemia secondary to protein loss from the gastrointestinal tract. We report a case of Lupus protein-losing enteropathy (LUPPLE) as the presenting feature of systemic lupus erythematosus (SLE).
Our patient presented with 4 months of watery, non-bloody, diarrhoea (maximum of 10 stools per day) and significant weight loss. Later she developed severe peripheral oedema, malar and maculopapular erythematous rash in the thorax and limbs. Blood analysis showed anaemia, severe hypoalbuminemia, hypokalaemia, hypomagnesemia.
During the investigation proteinuria and other causes of hypoalbuminemia were excluded and a thorough differential diagnosis regarding the main causes of PLE was made. Positive Antinuclear and anti-ribonucleoprotein antibodies were found and LUPPLE was diagnosed. The patient was started on methylprednisolone pulses 1000 mg/day for 3 days, followed prednisolone 1 mg/kg/day, with great clinical response.
After 20 days, azathioprine was added as the tapering of corticosteroids ensued.
This clinical case portraits PLE as a rare form of presentation of SLE that, due to its uncommonness, can result in a missed diagnosis with consequent increase in morbidity and mortality.
Downloads
References
Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic criteria for systemic lupus erythematosus: has the time come? Nat Rev Rheumatol. 2013; 9:687–94. doi: 10.1038/nrrheum.2013.103
Chen Z, Li M-T, Xu D, Yang H, Li J, Zhao J-L, et al. Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years’ Experience from a Chinese Academic Center. PLoS One. 2014; 1-14. doi.org/10.1371/journal. pone.0114684
Al-Mogairen SM. Lupus protein-losing enteropathy (LUPLE): a systematic review. Rheumatol Int. 2011; 31: 995-1001. doi: 10.1007/s00296-011-1827-9.
Ianiro G, Bibbo S, Montalto M, Ricci R, Gasbarrini A. Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014; 40: 16–23. doi: 10.1111/apt.12780
Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, et al. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014; 40: 1103. doi: 10.1111/apt.12937
Rubin RL. Drug-induced lupus, Expert Opinion Drug Safety 2015; 361-78. doi: 10.1517/14740338.2015.995089
Gray T, Segars K, Farsi M, Ross R, Miller R. Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan. Dermatol Online J. 2019; 13030. doi: 10.5070/D32512046719